期刊文献+

乳腺癌治疗中TE方案新辅助化疗的应用效果及机制 被引量:3

The application effect and mechanism of TE plan new adjuvant chemotherapy for breast cancer
下载PDF
导出
摘要 目的观察并研究乳腺癌治疗中TE方案新辅助化疗的应用效果及机制。方法选取2010年1月~2012年1月在笔者所在医院治疗的40例乳腺癌患者,采取TE方案新辅助进行化疗,并观察其疗效。结果 40例患者,完全缓解11例,部分缓解为21例,病情稳定为8例,疾病进展为0例,总的有效率为80%。本研究中的患者均能对其出现的不良反应耐受,且在化疗的过程中未发现腹泻、肝肾功能或心电图出现异常的患者。结论 TE方案新辅助化疗对治疗乳腺癌有良好的应用效果,能大幅度地提高乳腺癌的化疗有效率,值得临床上运用于治疗乳腺癌。 Objective To observe and study the application effect and mechanism of TE plan new adjuvant chemotherapy for breast cancer.Methods 40 cases with breast cancer in our hospital from January 2010 to January 2012 took the TE scheme neoadjuvant chemotherapy and observed its efficacy.Results Among the 40 cases,11 patients completely relieved,21 patients part of relieved,8 patients in stable condition,had no patients disease progress,the total effective rate was 80%.All the patients could tolerance for the adverse reaction,there had no patients of diarrhea,liver and kidney function or abnormal electrocardiogram in the chemotherapy process.Conclusion TE plan new adjuvant chemotherapy in the treatment of breast cancer have a good application effect,and can greatly improve efficient of breast cancer chemotherapy,it is worth clinical use in the treatment of breast cancer.
作者 周林平
出处 《中国医药科学》 2012年第22期187-188,共2页 China Medicine And Pharmacy
关键词 TE方案 乳腺癌 新辅助化疗 效果 TE scheme Breast cancer New adjuvant chemotherapy Effect
  • 相关文献

参考文献5

二级参考文献26

  • 1程琳,乔新民,杨德启,佟富中,周波,曹迎明,刘鹏,刘宏军,王殊,刘淼,张嘉庆.乳腺癌保乳手术治疗148例分析[J].中国微创外科杂志,2004,4(4):276-278. 被引量:43
  • 2傅俊惠,柯斌,杨楚徐,黄培生,黄建豪,郑海波,郑春鹏,吴智勇.保留皮肤及乳头乳晕的皮下乳腺癌改良根治术同期乳房重建32例报告[J].中国实用外科杂志,2005,25(1):54-55. 被引量:21
  • 3潘启超.吡柔比星的药理与临床[J].中国新药杂志,1995,4(6):20-23. 被引量:27
  • 4江丰收,崔健,林新民,庄建生,胡冰.吡柔比星联合治疗乳腺癌疗效观察[J].安徽医科大学学报,1997,32(2):127-129. 被引量:6
  • 5胥彬 张雄文.阿霉素、表柔比星、吡柔比星等蒽环类抗癌抗生素的药理与临床应用[J].中国肿瘤临床(吡柔比星(THP)临床应用专辑),1999,:9-17.
  • 6Herait P, Poutignat N, Marty M, et al.Early assessment of a new anticancer drug analogue are the historical comparisons obsolete? The French Experience with pirarubicin[J]. Eur J Cancer, 1992,28A:1670.
  • 7Brincker H. Distant recurrence in breast cancer. Survival expectations and first choice of chemotherapy regimen[J]. Acta Oncol,1988,27(6A) :729-732.
  • 8Tominage T. A randomized controlled study of ( 2''R )-4'-O-tetrahydropy-ranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer.Clinical Study Group of THP for Breast Cancer in Japan [J]. Biomed-pharmacother, 1989,43 (4):271 - 278.
  • 9Tatuo S,Yoichi K,Akira W,et al. Multi-insitutional cooperative study. Phase Ⅱ study of (2''rR)-4-O-tetrahy dropyrany-ladriamycin (THP) in patients with solid tumors [J]. Jpn J Cancer Chemother, 1986,13 (4) : 1060.
  • 10Pierga JY, Mouret E, Dieras V, et al. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer[J]. BrJ Cancer, 2000, 83(11): 1480~1487.

共引文献26

同被引文献22

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部